Vetra BiomaterialsJun 27, 20201 min readUFSCar develops a glass scaffoldThe product has low risk of infection, according to the research results. It is expected that in five years the graft can be applied in humans. Click the Image to see the full text.
The product has low risk of infection, according to the research results. It is expected that in five years the graft can be applied in humans. Click the Image to see the full text.
Comments